These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 35953094)

  • 1. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
    Kong C; Liang L; Liu G; Du L; Yang Y; Liu J; Shi D; Li X; Ma Y
    Gut; 2023 Jun; 72(6):1129-1142. PubMed ID: 35953094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
    Avuthu N; Guda C
    Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
    Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits.
    Shiroma H; Shiba S; Erawijantari PP; Takamaru H; Yamada M; Sakamoto T; Kanemitsu Y; Mizutani S; Soga T; Saito Y; Shibata T; Fukuda S; Yachida S; Yamada T
    mSystems; 2022 Apr; 7(2):e0001822. PubMed ID: 35311577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
    Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
    J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers.
    Li J; Guo Y; Liu J; Guo F; Du L; Yang Y; Li X; Ma Y
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37597851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 9. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
    Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
    Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Analysis of Colorectal Cancer Reveals Cross-Cohort Gut Microbial Signatures and Associated Serum Metabolites.
    Gao R; Wu C; Zhu Y; Kong C; Zhu Y; Gao Y; Zhang X; Yang R; Zhong H; Xiong X; Chen C; Xu Q; Qin H
    Gastroenterology; 2022 Oct; 163(4):1024-1037.e9. PubMed ID: 35788345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
    Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
    Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
    Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
    Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
    Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the gut microbiome, metabolites, and multi-omics biomarkers across the colorectal cancer care continuum.
    Wu Y; Shen N; Hope C; Noh HI; Richardson BN; Swartz MC; Bai J
    Benef Microbes; 2024 Aug; 15(6):539-563. PubMed ID: 39147373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes.
    Nakatsu G; Zhou H; Wu WKK; Wong SH; Coker OO; Dai Z; Li X; Szeto CH; Sugimura N; Lam TY; Yu AC; Wang X; Chen Z; Wong MC; Ng SC; Chan MTV; Chan PKS; Chan FKL; Sung JJ; Yu J
    Gastroenterology; 2018 Aug; 155(2):529-541.e5. PubMed ID: 29689266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
    Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
    Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-Onset/Young-Onset Colorectal Carcinoma: A Comparative Analysis of Morphological Features and Biomarker Profile.
    Hashmi AA; Aslam M; Rashid K; Ali AH; Dowlah TU; Malik UA; Zia S; Sham S; Zia F; Irfan M
    Cureus; 2023 Jul; 15(7):e42340. PubMed ID: 37621838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation.
    Thomas AM; Manghi P; Asnicar F; Pasolli E; Armanini F; Zolfo M; Beghini F; Manara S; Karcher N; Pozzi C; Gandini S; Serrano D; Tarallo S; Francavilla A; Gallo G; Trompetto M; Ferrero G; Mizutani S; Shiroma H; Shiba S; Shibata T; Yachida S; Yamada T; Wirbel J; Schrotz-King P; Ulrich CM; Brenner H; Arumugam M; Bork P; Zeller G; Cordero F; Dias-Neto E; Setubal JC; Tett A; Pardini B; Rescigno M; Waldron L; Naccarati A; Segata N
    Nat Med; 2019 Apr; 25(4):667-678. PubMed ID: 30936548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer.
    Yachida S; Mizutani S; Shiroma H; Shiba S; Nakajima T; Sakamoto T; Watanabe H; Masuda K; Nishimoto Y; Kubo M; Hosoda F; Rokutan H; Matsumoto M; Takamaru H; Yamada M; Matsuda T; Iwasaki M; Yamaji T; Yachida T; Soga T; Kurokawa K; Toyoda A; Ogura Y; Hayashi T; Hatakeyama M; Nakagama H; Saito Y; Fukuda S; Shibata T; Yamada T
    Nat Med; 2019 Jun; 25(6):968-976. PubMed ID: 31171880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts.
    Liu NN; Jiao N; Tan JC; Wang Z; Wu D; Wang AJ; Chen J; Tao L; Zhou C; Fang W; Cheong IH; Pan W; Liao W; Kozlakidis Z; Heeschen C; Moore GG; Zhu L; Chen X; Zhang G; Zhu R; Wang H
    Nat Microbiol; 2022 Feb; 7(2):238-250. PubMed ID: 35087227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.